Table 3.

Characteristics of each cost-effectiveness analysis (CEA) for venous and venous/arterial ulcers (n = 2)

CEA (Original year of values)	Country (Original currency)	Perspective	Efficacy study design	Sample size	Population	Timeframe	Funding source
Dumville 2009 (2006) [46]	UK (£)	Public payer	RCT	267	Mean 74 yrs; venous insufficiency	52 wks	Not reported
Ohlsson 1994 (1993) [47]	Sweden (SEK)	Not reported	RCT	30	Median 76 yrs; venous insufficiency; most female	6 wks	Not reported

RCT, Randomized clinical trial; WKS, Weeks; Yrs, Years.